Showing 2511-2520 of 23150 results for "".
A Treatment for Acute Manic or Mixed Episodes of Bipolar I Disorder in Adults
https://reachmd.com/industry-feature/psychiatry-and-mental-health/treatment-acute-manic-mixed-episodes-bipolar-I-disorder-adults/7534/Please see Important Safety Information, including Boxed Warning. Host Dr. Matt Birnholz welcomes Dr. Roger McIntyre...A Treatment for Schizophrenia in Adults
https://reachmd.com/industry-feature/psychiatry-and-mental-health/treatment-schizophrenia-adults/7535/Please see Important Safety Information, including Boxed Warning.Host Dr. Matt Birnholz and guest expert, Dr. Roger McIntyre...The Biologic Coordinator: Your Partner to Access
https://reachmd.com/programs/practical-dermatology/the-biologic-coordinator-your-partner-to-access/24032/As the biologics market has increased, so might your practice’s need for a biologic coordinator.Clinical Neuroinflammatory Mimics of Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/clinical-neuroinflammatory-mimics-of-multiple-sclerosis/54599/NMOSD, MOGAD, and MS have overlapping clinical presentations but are distinct inflammatory CNS diseases, each with their own established diagnostic criteria.MS Minute: Update on BTK Inhibitors for Multiple Sclerosis—A New Treatment That Brings New Hope
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/update-on-btk-inhibitors-for-multiple-sclerosis-a-new-treatment-that-brings-new-hope/40007/BTK inhibitors are the first class of medications to slow disability progression in secondary progressive multiple sclerosis without clinical relapses.Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
https://reachmd.com/programs/cme/Signaling-for-Sustained-Change-Spotlight-on-the-Potential-of-TKIs-to-Deliver-Durable-Control-of-Exudative-Retinal-Disease/39934/Explore the clinical promise of TKIs in managing exudative retinal diseases with insights on mechanisms, delivery, trials, and patient selection.Epilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://reachmd.com/programs/practical-neurology-focus-on-epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
https://reachmd.com/programs/cme/a-case-of-missed-diagnosis-part-of-the-focused-sight-initiative-quality-improvement-interventions-in-retinal-disease/37713/Examine a case of misdiagnosed proliferative diabetic retinopathy, highlighting risk factors, imaging findings, and referral timing.Mitigating Risk in New IBD Treatments– IBD Pro Webinar Series
https://reachmd.com/programs/cme/mitigating-risk-in-new-ibd-treatments-ibd-pro-webinar-series/16004/Join us for this module of the IBD Pro Webinar Series presentation titled “How to Mitigate Risks in New Therapies”. The talk will include new medications, positioning, real world evidence, and the Foundation's EMR IBD Education Tool. The 45 minute presentation will be followed by a 15 minute quesFertility and Safety of IBD Medications During Pregnancy – IBD Pro Webinar Series
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/fertility-and-safety-of-ibd-medications-during-pregnancy-ibd-pro-webinar-series/16104/Join us for this IBD Pro Webinar Series presentation titled “Fertility and Safety of IBD Medications During Pregnancy”. The talk will include a discussion on fertility in IBD patients and the safety profile of IBD treatments during pregnancy. The 40-minute presentation will be followed by a 20-mi